HCV status knowledge and risk behaviours amongst intravenous drug users

被引:34
|
作者
Vidal-Trécan, G [1 ]
Coste, J [1 ]
Varescon-Pousson, I [1 ]
Christoforov, B [1 ]
Boissonnas, A [1 ]
机构
[1] Univ Paris 05, CHU Cochin Port Royal, Dept Sante Publ, Univ Praticien Hosp, Paris, France
关键词
hepatitis C; injecting behaviours; intravenous; sex behaviours; substance abuse;
D O I
10.1023/A:1007622831518
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to identify relationships between injecting and sexual risk behaviours and hepatitis C virus (HCV) status knowledge in intravenous drug users (IDUs). It was a cross-sectional survey (March 1994-June 1995) in 10 drug abuse treatment or psychosocial centres in Paris, France. We used a structured questionnaire about sexual, injecting, HIV and HCV antibody testing practices and results during the previous 6months. Six hundred and twelve sexually active IDUs aged 18 or older who were current injecting drug users were interviewed. Of 592 respondent IDUs, 37% did not report consistent HCV testing and 34% reported being HCV-positive. HCV-positive IDUs were older than HCV-negatives and HCV-unknowns. HCV-unknowns and HCV-positives had a lower educational level than HCV-negatives. After adjusting for demographic characteristics and HIV status, the factors associated with being HCV-unknown were not using condoms (OR: 2.9; 95% CI: 1.9-4.6) as well as clean equipment (OR: 1.8; 95% CI: 1.2-3.0). Not using new equipment was negatively associated with being HCV-unknown (OR: 0.4; 95% CI: 0.2-0.6) and with being HCV-positive (OR: 0.5; 95% CI: 0.3-0.8). Our study suggests that particular sexual and injecting risk-behaviours are associated with not knowing HCV status. As HCV-unknown IDUs are likely to be at the risk of transmitting HCV or acquiring other infections. HCV testing should be encouraged and associated with sexual counselling. Special attention should be paid to disinfecting practices for HCV-positives and use of new injecting equipment should be recommended for HCV-negatives.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
  • [11] Risk behaviours of illicit drug users while travelling
    Rihtar, Tatja Kostnapfel
    Svab, Igor
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (7-8): : 458 - 465
  • [12] Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France
    Lucidarme, D
    Bruandet, A
    Ilef, D
    Harbonnier, J
    Jacob, C
    Decoster, A
    Delamare, C
    Cyran, C
    Van Hoenacker, AF
    Frémaux, D
    Josse, P
    Emmanuelli, J
    Le Strat, Y
    Desenclos, JC
    Filoche, B
    EPIDEMIOLOGY AND INFECTION, 2004, 132 (04): : 699 - 708
  • [14] The HCV genotype 3A worldwide epidemics in intravenous drug users
    Morice, Y
    Cantaloube, JF
    Beaucourt, S
    de Gendt, S
    Goncales, FL
    Butterworth, LA
    Cooksley, GE
    Thomas, DL
    Gish, RG
    Beaugrand, M
    Fay, F
    Fay, O
    Gonzalez, J
    Martins, RMB
    Dhumeaux, D
    Vanderborght, B
    Stuyver, L
    Sablon, E
    de Lamballerie, X
    Pawlotsky, JM
    HEPATOLOGY, 2004, 40 (04) : 177A - 177A
  • [15] HCV-specific cellular immune responses in intravenous drug users without HCV infection
    Thurairajah, Prem H.
    Hegazy, Doha M.
    Richardon, Sarah J.
    Demaine, Andy G.
    Kaminski, Edward R.
    Cramp, Matthew E.
    HEPATOLOGY, 2007, 46 (04) : 240A - 241A
  • [16] Drug and sexual HIV risk behaviours related to knowledge of HIV serostatus among injection drug users in Houston, Texas
    Noor, Syed W. B.
    Ross, Michael W.
    Lai, Dejian
    Risser, Jan M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (02) : 89 - 95
  • [17] KNOWLEDGE OF HIV ANTIBODY STATUS AND DECISIONS TO CONTINUE OR TERMINATE PREGNANCY AMONG INTRAVENOUS DRUG-USERS
    SELWYN, PA
    CARTER, RJ
    SCHOENBAUM, EE
    ROBERTSON, VJ
    KLEIN, RS
    ROGERS, MF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24): : 3567 - 3571
  • [18] Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the north and east of France.
    Lucidarme, D
    Bruandet, A
    Ilef, D
    Harbonnier, J
    Jacob, C
    Decoste, A
    Delamare, C
    Cyran, C
    Van Hoenacker, AF
    Fremaux, D
    Fremaux, D
    Josse, P
    Emmanuelli, J
    Le Strat, Y
    Desenclos, JC
    Filoche, B
    HEPATOLOGY, 2003, 38 (04) : 447A - 447A
  • [19] The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China
    Tao, Jun
    Liang, Jun
    Zhang, Hui
    Pei, Lijian
    Qian, Han-zhu
    Chambers, Matthew C.
    Jiang, Yan
    Xiao, Yao
    PLOS ONE, 2015, 10 (10):
  • [20] Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities
    Nasir, Abdul
    Todd, Catherine S.
    Stanekzai, M. Raza
    Bautista, Christian T.
    Botros, Boulos A.
    Scott, Paul T.
    Strathdee, Steffanie A.
    Tjaden, Jeffrey
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (02) : 145 - 152